Radhika Tripuraneni - 26 Jul 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Radhika Tripuraneni
Issuer symbol
TERN
Transactions as of
26 Jul 2022
Net transactions value
$0
Form type
4
Filing time
28 Jul 2022, 20:08:05 UTC
Previous filing
25 Feb 2022
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +64,000 $0.000000 64,000 26 Jul 2022 Common Stock 64,000 $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares subject to the option vest on the first anniversary measured from July 26, 2022 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.